Senseonics Holdings Inc (NYSEMKT:SENS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Friday.

According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

Several other analysts also recently weighed in on SENS. Canaccord Genuity reissued a “buy” rating and set a $6.00 target price on shares of Senseonics Holdings in a research report on Wednesday, August 10th. B. Riley reissued a “buy” rating and set a $5.00 target price on shares of Senseonics Holdings in a research report on Monday. Finally, Leerink Swann reissued an “outperform” rating and set a $6.00 target price (up previously from $4.50) on shares of Senseonics Holdings in a research report on Thursday, September 22nd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $5.17.

Analyst Recommendations for Senseonics Holdings (NYSEMKT:SENS)

Senseonics Holdings (NYSEMKT:SENS) opened at 2.44 on Friday. The firm has a 50-day moving average of $2.94 and a 200 day moving average of $3.51. Senseonics Holdings has a 52-week low of $2.17 and a 52-week high of $4.24. The company’s market capitalization is $227.87 million.

Senseonics Holdings (NYSEMKT:SENS) last posted its quarterly earnings data on Thursday, November 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.01. Equities analysts predict that Senseonics Holdings will post ($0.51) earnings per share for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in the stock. Highland Capital Management LLC purchased a new stake in shares of Senseonics Holdings during the third quarter worth about $116,000. Oak Ridge Investments LLC purchased a new stake in shares of Senseonics Holdings during the third quarter worth about $125,000. Teachers Advisors Inc. purchased a new stake in shares of Senseonics Holdings during the second quarter worth about $175,000. Schwab Charles Investment Management Inc. purchased a new stake in shares of Senseonics Holdings during the second quarter worth about $180,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Senseonics Holdings during the second quarter worth about $222,000.

About Senseonics Holdings

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.